Company: TYRA
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0000950170-25-046124
Chunk: 208

Company: Tyra Biosciences, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1B
Chunk 208
---
 Statements.

The financial statements of Tyra Biosciences, Inc., together with the report thereon of Ernst & Young LLP, an independent registered public accounting firm (PCAOB ID No. 42), are included in this Annual Report contained in Part II, Item 8. Financial Statements and Supplementary Data. 

2.Finance Statement Schedules.

All schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto. 

3.Exhibits.

A list of exhibits is set forth on the Exhibit Index immediately preceding the signature page of this Annual Report and is incorporated herein by reference. 

Item 16. Form 10-K Summary.

None.

140

EXHIBIT INDEX

    ExhibitNumber
     
    Exhibit Description
     
    Incorporated by Reference
     
    FiledHerewith

    Form
     
    Date
     
    Number

    3.1
     
    Amended and Restated Certificate of Incorporation
     
    10-K
     
    3/22/23
     
    3.1

    3.2
     
    Amended and Restated Bylaws, effective as of October 26, 2023
     
    8-K
     
    10/26/23
     
    3.1

    4.1
     
    Specimen stock certificate evidencing the shares of common stock
     
    S-1
     
    8/20/21
     
    4.1

    4.2
     
    Amended and Restated Investors’ Rights Agreement, dated March 5, 2021, by and among the Registrant and certain of its stockholders
     
    S-1/A
     
    9/9/21
     
     4.2

    4.3
     
    Description of Registered Securities
     
    10-K
     
    3/3/22
     
    4.3

    4.4
     
    Form of Pre-Funded Warrant
     
    8-K
     
    2/5/24
     
    4.1

    10.1#
     
    Tyra Biosciences, Inc. 2020 Equity Incentive Plan and form of stock option agreement thereunder
     
    S-1
     
    8/20/21
     
    10.